Your browser doesn't support javascript.
loading
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways.
Steele, Christopher D; Tarabichi, Maxime; Oukrif, Dahmane; Webster, Amy P; Ye, Hongtao; Fittall, Matthew; Lombard, Patrick; Martincorena, Iñigo; Tarpey, Patrick S; Collord, Grace; Haase, Kerstin; Strauss, Sandra J; Berisha, Fitim; Vaikkinen, Heli; Dhami, Pawan; Jansen, Marnix; Behjati, Sam; Amary, M Fernanda; Tirabosco, Roberto; Feber, Andrew; Campbell, Peter J; Alexandrov, Ludmil B; Van Loo, Peter; Flanagan, Adrienne M; Pillay, Nischalan.
Afiliación
  • Steele CD; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK.
  • Tarabichi M; Cancer Genomics Laboratory, The Francis Crick Institute, London NW1 1BF, UK.
  • Oukrif D; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK.
  • Webster AP; Department of Cancer Biology, UCL Cancer Institute, University College London, London, UK.
  • Ye H; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Fittall M; Cancer Genomics Laboratory, The Francis Crick Institute, London NW1 1BF, UK.
  • Lombard P; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK.
  • Martincorena I; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Tarpey PS; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Collord G; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London NW1 1BF, UK.
  • Strauss SJ; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK; Department of Oncology, University College London Hospital NHS Foundation Trust, London, NW1 2PG, UK.
  • Berisha F; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Vaikkinen H; Genomics and Genome Engineering Core Facility, CRUK-UCL Centre, Cancer Institute, University College London, London WC1E 6BT, UK; Research Department of Oncology, Cancer Institute, University College London, London WC1E 6BT, UK.
  • Dhami P; Genomics and Genome Engineering Core Facility, CRUK-UCL Centre, Cancer Institute, University College London, London WC1E 6BT, UK.
  • Jansen M; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK; Department of Cellular Pathology, University College London Hospital NHS Foundation Trust, London NW1 2BU, UK.
  • Behjati S; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Amary MF; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Tirabosco R; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Feber A; Department of Targeted Intervention, Division of Surgery and Interventional Science, University College London, London WC1E 6BT, UK.
  • Campbell PJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 2XY, UK.
  • Alexandrov LB; Department of Cellular and Molecular Medicine, University of California, San Diego 92093, USA.
  • Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London NW1 1BF, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium.
  • Flanagan AM; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Pillay N; Research Department of Pathology, Cancer Institute, University College London, London WC1E 6BT, UK; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK. Electronic address: n.pillay@ucl.ac.uk.
Cancer Cell ; 35(3): 441-456.e8, 2019 03 18.
Article en En | MEDLINE | ID: mdl-30889380
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Análisis de Secuencia de ADN / Metilación de ADN / Perfilación de la Expresión Génica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Análisis de Secuencia de ADN / Metilación de ADN / Perfilación de la Expresión Génica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido